CD34 and leukemia: The first definitive work describing TIC was performed in Acute Myeloid Leukemia where the surface marker phenotype CD34+, CD38− identifies a small subpopulation of cells that is able to propagate the leukemia, while CD34+ cells that express CD38 cannot, despite having the morphologic phenotype of leukemic blasts [16].